deCODE Announces Appointment of Peter Goodfellow to Board of Directors
15-Sep-2006
deCODE genetics announced that it has named Dr. Peter Goodfellow to its Board of Directors, effective immediately.
Dr. Goodfellow was until recently Senior Vice President for Discovery Research at GlaxoSmithKline, a position he held for the past six years. Prior to this post, he held senior positions at SmithKline Beecham, the Balfour chair in genetics at Cambridge University and research positions at the Imperial Cancer Research Fund. Dr. Goodfellow received his doctorate from Oxford University and held a postdoctoral fellowship at Stanford University.
Other news from the department people
